Two Tales: Hemorrhagic Transformation but Not Parenchymal Hemorrhage After Thrombolysis Is Related to Severity and Duration of Ischemia-Reference-Cited by-同舟云学术

Two Tales: Hemorrhagic Transformation but Not Parenchymal Hemorrhage After Thrombolysis Is Related to Severity and Duration of Ischemia

Published:2007-02 Issue:2 Volume:38 Page:313-318
ISSN:0039-2499
Container-title:Stroke
language:en
Short-container-title:Stroke

Author:

Thomalla Götz¹,Sobesky Jan¹,Köhrmann Martin¹,Fiebach Jochen B.¹,Fiehler Jens¹,Zaro Weber Olivier¹,Kruetzelmann Anna¹,Kucinski Thomas¹,Rosenkranz Michael¹,Röther Joachim¹,Schellinger Peter D.¹

Affiliation:

1. From Klinik und Poliklinik für Neurologie (G.T., A.K., M.R.), Neuro-Zentrum; Neuroradiologische Abteilung (J.F., T.K.), Klinik und Poliklinik für Radiologie, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany; Klinik und Poliklinik für Neurologie der Universität zu Köln (J.S., O.Z.W.), Köln, Germany; Neurologische Klinik (M.K., P.D.S.), Universitätsklinikum Erlangen, Erlangen, Germany; Klinik und Poliklinik für Neurologie, Charité- Universitätsmedizin Berlin, Berlin, Germany (J.B.F....

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Advanced and Specialized Nursing,Cardiology and Cardiovascular Medicine,Neurology (clinical)

Reference27 articles.

1. Intravenous Tissue-Type Plasminogen Activator for Treatment of Acute Stroke

2. Tissue Plasminogen Activator for Acute Ischemic Stroke in Clinical Practice

3. Reperfusion after Severe Local Perfusion Deficit Precedes Hemorrhagic Transformation: An MRI Study in Acute Stroke Patients

Cited by 108 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. lncRNA DHFRL1‑4 knockdown attenuates cerebral ischemia/reperfusion injury by upregulating the levels of angiogenesis‑related genes;International Journal of Molecular Medicine;2022-06-22

2. Tenecteplase versus Alteplase for Stroke Thrombolysis Evaluation Trial in the Ambulance (Mobile Stroke Unit—TASTE-A): protocol for a prospective randomised, open-label, blinded endpoint, phase II superiority trial of tenecteplase versus alteplase for ischaemic stroke patients presenting within 4.5 hours of symptom onset to the mobile stroke unit;BMJ Open;2022-04

3. Hemorrhagic Transformation in Acute Ischemic Stroke: A Quantitative Systematic Review;Journal of Clinical Medicine;2022-02-22

4. Neuroimaging Prediction of Hemorrhagic Transformation for Acute Ischemic Stroke;Cerebrovascular Diseases;2022

5. Editorial: Intracranial Bleeding After Reperfusion Therapy in Acute Ischemic Stroke;Frontiers in Neurology;2021-08-31